Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nadja Thomas"'
Autor:
Irina Kiprianova, Ali Ayache, Michele Klein, Nadja Thomas, Barbara Leuchs, Manuel Fischer, Joerg R. Schlehofer, Jean Rommelaere
Publikováno v:
Clinical Cancer Research. 17:5333-5342
Purpose: In previous studies, we have shown that the apathogenic rat parvovirus H-1 (H-1PV) is capable to induce regression of advanced symptomatic rat and human gliomas in a rat model, when the virus was injected in the tumor (intracranially) or int
Autor:
Irina Kiprianova, Jean Rommelaere, Ali Ayache, Nadja Thomas, Clemens Sommer, R. M. Koch, Marta Herrero y Calle, Karsten Geletneky, Jörg R. Schlehofer, Laurent Deleu
Publikováno v:
Neuro-Oncology. 12:804-814
Oncolytic virotherapy is a potential treatment modality under investigation for various malignancies including malignant brain tumors. Unlike some other natural or modified viruses that show oncolytic activity against cerebral neoplasms, the rodent p
Autor:
Sabine Merkelbach-Bruse, Daniel Pink, Thomas Heinicke, Peter Reichardt, Peter Hohenberger, Eva Wardelmann, Nadja Thomas, Nicola Speidel, Reinhard Buettner, Torsten Pietsch, Hans-Ulrich Schildhaus, Katharina Pauls
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 12(6)
Gastrointestinal stromal tumors (GIST) are characterized by a strong KIT receptor activation most often resulting from KIT mutations. In a smaller subgroup of tumors without KIT mutations, analogous activating mutations are found in the platelet-deri
Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations
Autor:
Katharina Pauls, Claudia Leutner, Heiner Bihl, Reinhard Büttner, Eva Wardelmann, Nadja Thomas, Nicola Speidel, Thomas Heinicke, Sabine Merkelbach-Bruse, Peter Hohenberger
Publikováno v:
The Lancet. Oncology. 6(4)
Autor:
Eva Wardelmann, Katharina Biermann, Sabine Merkelbach-Bruse, Hans-Ulrich Schildhaus, Nadja Thomas, Reinhard Büttner, Torsten Pietsch, Thomas Heinicke, Nicola Speidel, Daniel Pink, Peter Reichardt, Peter Hohenberger
Publikováno v:
Clinical Cancer Research. 12:6206-6206